Please login to the form below

Not currently logged in
Email:
Password:

Professor Carole Longson moves from NICE to the ABPI

She joins the UK pharma body as its chief scientific officer

The Association of the British Pharmaceutical Industry (ABPI) has attracted Professor Carole Longson away from the National Institute for Health and Care Excellence (NICE) to be its new chief scientific officer, handing her responsibility for leading the UK trade body's research, medical and innovation functions.

She will also shape and develop UK pharmaceutical science policy and will ensure that the UK “remains at the forefront of innovation in medicines research, development and manufacturing”.

Mike Thompson, chief executive of the ABPI, said: “The appointment of Carole to this new post signals our commitment to strengthening our focus on science, research and discovery in the UK and the role our members play in developing new innovative medicines and vaccines.

“Her scientific research and academic experience, along with her integrity, perspective and vision can really help us continue to transform the pharmaceutical industry in the UK.”

Longson brings research, academic and pharmaceutical industry experience to the ABPI, including seven years as a research lead at GlaxoSmithKline.

She most recently spent the 18 years at the National Institute for Health and Care Excellence (NICE), where she has led the HTA organisation’s technology appraisal programme.

Neil Weir, chair of the ABPI innovation board, said: “I am delighted by the appointment of Carole to the role of chief scientific officer at the ABPI and her significant scientific experience, expertise and network in both industry and academia will enable the ABPI to work with our partners to further these objectives.”

30th January 2018

From: Regulatory

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics